Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Diogo A. Tschoeke is active.

Publication


Featured researches published by Diogo A. Tschoeke.


Scientific Reports | 2017

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication.

Carolina Q. Sacramento; Gabrielle R. de Melo; Caroline S. de Freitas; Natasha Rocha; Lucas V. B. Hoelz; Milene Miranda; Natalia Fintelman-Rodrigues; Andressa Marttorelli; André C. Ferreira; Giselle Barbosa-Lima; Juliana L. Abrantes; Yasmine Rangel Vieira; Mônica M. Bastos; Eduardo de Mello Volotão; Estevão Portela Nunes; Diogo A. Tschoeke; Luciana Leomil; Erick Correia Loiola; Pablo Trindade; Stevens K. Rehen; Fernando A. Bozza; Patricia T. Bozza; Núbia Boechat; Fabiano L. Thompson; Ana Maria Bispo de Filippis; Karin Brüning; Thiago Moreno L. Souza

Zika virus (ZIKV) is a member of the Flaviviridae family, along with other agents of clinical significance such as dengue (DENV) and hepatitis C (HCV) viruses. Since ZIKV causes neurological disorders during fetal development and in adulthood, antiviral drugs are necessary. Sofosbuvir is clinically approved for use against HCV and targets the protein that is most conserved among the members of the Flaviviridae family, the viral RNA polymerase. Indeed, we found that sofosbuvir inhibits ZIKV RNA polymerase, targeting conserved amino acid residues. Sofosbuvir inhibited ZIKV replication in different cellular systems, such as hepatoma (Huh-7) cells, neuroblastoma (SH-Sy5y) cells, neural stem cells (NSC) and brain organoids. In addition to the direct inhibition of the viral RNA polymerase, we observed that sofosbuvir also induced an increase in A-to-G mutations in the viral genome. Together, our data highlight a potential secondary use of sofosbuvir, an anti-HCV drug, against ZIKV.


Nucleic Acids Research | 2007

ProtozoaDB: dynamic visualization and exploration of protozoan genomes.

Alberto M. R. Dávila; Pablo N. Mendes; Glauber Wagner; Diogo A. Tschoeke; Rafael R. C. Cuadrat; Felipe Liberman; Luciana Matos; Thiago S. Satake; Kary A. C. S. Ocaña; Omar Triana; Sérgio Manuel Serra da Cruz; Henrique Jucá; Juliano C. Cury; Fabrício Nogueira da Silva; Guilherme A. Geronimo; Margarita Ruiz; Eduardo Ruback; Floriano P. Silva; Christian M. Probst; Edmundo Carlos Grisard; Marco Aurélio Krieger; Samuel Goldenberg; Maria Cláudia Cavalcanti; Milton Ozório Moraes; Maria Luiza Machado Campos; Marta Mattoso

ProtozoaDB (http://www.biowebdb.org/protozoadb) is being developed to initially host both genomics and post-genomics data from Plasmodium falciparum, Entamoeba histolytica, Trypanosoma brucei, T. cruzi and Leishmania major, but will hopefully host other protozoan species as more genomes are sequenced. It is based on the Genomics Unified Schema and offers a modern Web-based interface for user-friendly data visualization and exploration. This database is not intended to duplicate other similar efforts such as GeneDB, PlasmoDB, TcruziDB or even TDRtargets, but to be complementary by providing further analyses with emphasis on distant similarities (HMM-based) and phylogeny-based annotations including orthology analysis. ProtozoaDB will be progressively linked to the above-mentioned databases, focusing in performing a multi-source dynamic combination of information through advanced interoperable Web tools such as Web services. Also, to provide Web services will allow third-party software to retrieve and use data from ProtozoaDB in automated pipelines (workflows) or other interoperable Web technologies, promoting better information reuse and integration. We also expect ProtozoaDB to catalyze the development of local and regional bioinformatics capabilities (research and training), and therefore promote/enhance scientific advancement in developing countries.


bioRxiv | 2016

The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication

Caroline Q. Sacramento; Gabrielle R. de Melo; Natasha Rocha; Lucas Villas Boas Hoelz; Milene Mesquita; Caroline S. de Freitas; Natalia Fintelman-Rodrigues; Andressa Marttorelli; André C. Ferreira; Giselle Barbosa-Lima; Mônica M. Bastos; Eduardo de Mello Volotão; Diogo A. Tschoeke; Luciana Leomil; Fernando A. Bozza; Patricia T. Bozza; Núbia Boechat; Fabiano L. Thompson; Ana Maria Bispo de Filippis; Karin Brüning; Thiago Moreno L. Souza

Zika virus (ZIKV) is a member of Flaviviridae family, as other agents of clinical significance, such as dengue (DENV) and hepatitis C (HCV) viruses. ZIKV spread from Africa to Pacific and South American territories, emerging as an etiological pathogen of neurological disorders, during fetal development and in adulthood. Therefore, antiviral drugs able to inhibit ZIKV replication are necessary. Broad spectrum antivirals, such as interferon, ribavirin and favipiravir, are harmful for pregnant animal models and women. The clinically approved uridine nucleotide analog anti-HCV drug, sofosbuvir, has not been affiliated to teratogenicity. Sofosbuvir target the most conserved protein over the members of the Flaviviridae family, the viral RNA polymerase. We thus studied ZIKV susceptibility to sofosbovir. We initially characterized a Brazilian ZIKV strain for use in experimental assays. Sofosbuvir inhibits the Brazilian ZIKV replication in a dose-dependent manner, both in BHK-21 cells and SH-Sy5y, by targeting ZIKV RNA polymerase activity, with the involvement of conserved amino acid residues over the members of Flaviviridae family. The identification of clinically approved antiviral drugs endowed with anti-ZIKV could reduce the time frame in pre-clinical development. Altogether, our data indicates that sofosbuvir chemical structure is endowed with anti-ZIKV activity.


PeerJ | 2016

Comparative genomics of Synechococcus and proposal of the new genus Parasynechococcus

Felipe H. Coutinho; Diogo A. Tschoeke; Fabiano L. Thompson; Cristiane C. Thompson

Synechococcus is among the most important contributors to global primary productivity. The genomes of several strains of this taxon have been previously sequenced in an effort to understand the physiology and ecology of these highly diverse microorganisms. Here we present a comparative study of Synechococcus genomes. For that end, we developed GenTaxo, a program written in Perl to perform genomic taxonomy based on average nucleotide identity, average amino acid identity and dinucleotide signatures, which revealed that the analyzed strains are drastically distinct regarding their genomic content. Phylogenomic reconstruction indicated a division of Synechococcus in two clades (i.e. Synechococcus and the new genus Parasynechococcus), corroborating evidences that this is in fact a polyphyletic group. By clustering protein encoding genes into homologue groups we were able to trace the Pangenome and core genome of both marine and freshwater Synechococcus and determine the genotypic traits that differentiate these lineages.


Marine Drugs | 2015

New Insights on the Terpenome of the Red Seaweed Laurencia dendroidea (Florideophyceae, Rhodophyta)

Louisi de Oliveira; Diogo A. Tschoeke; Aline Santos de Oliveira; Lilian Jorge Hill; Wladimir Costa Paradas; Leonardo T. Salgado; Cristiane C. Thompson; Renato Crespo Pereira; Fabiano L. Thompson

The red seaweeds belonging to the genus Laurencia are well known as halogenated secondary metabolites producers, mainly terpenoids and acetogennins. Several of these chemicals exhibit important ecological roles and biotechnological applications. However, knowledge regarding the genes involved in the biosynthesis of these compounds is still very limited. We detected 20 different genes involved in the biosynthesis of terpenoid precursors, and 21 different genes coding for terpene synthases that are responsible for the chemical modifications of the terpenoid precursors, resulting in a high diversity of carbon chemical skeletons. In addition, we demonstrate through molecular and cytochemical approaches the occurrence of the mevalonate pathway involved in the biosynthesis of terpenes in L. dendroidea. This is the first report on terpene synthase genes in seaweeds, enabling further studies on possible heterologous biosynthesis of terpenes from L. dendroidea exhibiting ecological or biotechnological interest.


Journal of Virological Methods | 2017

Development of standard methods for Zika virus propagation, titration, and purification

Sharton V. A. Coelho; Rômulo L.S. Neris; Michelle Premazzi Papa; Laila C. Schnellrath; Lana Monteiro Meuren; Diogo A. Tschoeke; Luciana Leomil; Brunno Renato Farias Verçoza; Milene Miranda; Fabiano L. Thompson; Andrea T. Da Poian; Thiago Moreno L. Souza; Fabiana A. Carneiro; Clarissa R. Damaso; Iranaia Assunção-Miranda; Luciana Barros de Arruda

The emergence of Zika virus (ZIKV) infection has stimulated several research groups to study and collaborate to understand virus biology and pathogenesis. These efforts may assist with the development of antiviral drugs, vaccines and diagnostic tests, as well as to promote advancements in public health policies. Here, we aim to develop standard protocols for propagation, titration, and purification of ZIKV strains, by systematically testing different cell types, kinetics, multiplicity of infection and centrifugation protocols. ZIKV produces a productive infection in human, non-human primate, and rodents-derived cell lines, with different efficacies. The highest yield of ZIKV-AFR and ZIKV-BR infectious progeny was obtained at 7days post infection in C6/36 cells (7×107 and 2×108 PFU/ml, respectively). However, high titers of ZIKV-AFR could be obtained at earlier time points in Vero cells (2.5×107PFU/ml at 72hpi), whereas ZIKV-BR titers reached 108 PFU/ml at 4dpi in C6/36 cells. High yield of purified virus was obtained by purification through a discontinuous sucrose gradient. This optimized procedure will certainly contribute to future studies of virus structure and vaccine development. Beyond the achievement of efficient virus propagation, the normalization of these protocols will also allow different laboratories around the world to better compare and discuss data regarding different features of ZIKV biology and disease, contributing to more efficient collaborations and progression in ZIKV research.


Evolutionary Bioinformatics | 2014

The Comparative Genomics and Phylogenomics of Leishmania amazonensis Parasite

Diogo A. Tschoeke; Gisele L Nunes; Rodrigo Jardim; Joana Lima; Aline Sr Dumaresq; Monete Rajão Gomes; Leandro de Mattos Pereira; Daniel R Loureiro; Patrícia Hermes Stoco; Herbert L.M. Guedes; Antonio Miranda; Jeronimo C. Ruiz; Floriano P. Silva; Christian M. Probst; Nicholas J. Dickens; Jeremy C. Mottram; Edmundo C. Grisard; Alberto M. R. Dávila

Leishmaniasis is an infectious disease caused by Leishmania species. Leishmania amazonensis is a New World Leishmania species belonging to the Mexicana complex, which is able to cause all types of leishmaniasis infections. The L. amazonensis reference strain MHOM/BR/1973/M2269 was sequenced identifying 8,802 codifying sequences (CDS), most of them of hypothetical function. Comparative analysis using six Leishmania species showed a core set of 7,016 orthologs. L. amazonensis and Leishmania mexicana share the largest number of distinct orthologs, while Leishmania braziliensis presented the largest number of inparalogs. Additionally, phylogenomic analysis confirmed the taxonomic position for L. amazonensis within the “Mexicana complex”, reinforcing understanding of the split of New and Old World Leishmania. Potential non-homologous isofunctional enzymes (NISE) were identified between L. amazonensis and Homo sapiens that could provide new drug targets for development.


PLOS ONE | 2016

Taxonomic and Functional Metagenomic Signature of Turfs in the Abrolhos Reef System (Brazil)

Juline M. Walter; Diogo A. Tschoeke; Pedro M. Meirelles; Louisi de Oliveira; Luciana Leomil; Márcio Murilo Barboza Tenório; Rogerio Valle; Paulo S. Salomon; Cristiane C. Thompson; Fabiano L. Thompson

Turfs are widespread assemblages (consisting of microbes and algae) that inhabit reef systems. They are the most abundant benthic component in the Abrolhos reef system (Brazil), representing greater than half the coverage of the entire benthic community. Their presence is associated with a reduction in three-dimensional coral reef complexity and decreases the habitats available for reef biodiversity. Despite their importance, the taxonomic and functional diversity of turfs remain unclear. We performed a metagenomics and pigments profile characterization of turfs from the Abrolhos reefs. Turf microbiome primarily encompassed Proteobacteria (mean 40.57% ± s.d. 10.36, N = 1.548,192), Cyanobacteria (mean 35.04% ± s.d. 15.5, N = 1.337,196), and Bacteroidetes (mean 11.12% ± s.d. 4.25, N = 424,185). Oxygenic and anoxygenic phototrophs, chemolithotrophs, and aerobic anoxygenic phototrophic (AANP) bacteria showed a conserved functional trait of the turf microbiomes. Genes associated with oxygenic photosynthesis, AANP, sulfur cycle (S oxidation, and DMSP consumption), and nitrogen metabolism (N2 fixation, ammonia assimilation, dissimilatory nitrate and nitrite ammonification) were found in the turf microbiomes. Principal component analyses of the most abundant taxa and functions showed that turf microbiomes differ from the other major Abrolhos benthic microbiomes (i.e., corals and rhodoliths) and seawater. Taken together, these features suggest that turfs have a homogeneous functional core across the Abrolhos Bank, which holds diverse microbial guilds when comparing with other benthic organisms.


Omics A Journal of Integrative Biology | 2014

An Orthology-Based Analysis of Pathogenic Protozoa Impacting Global Health: An Improved Comparative Genomics Approach with Prokaryotes and Model Eukaryote Orthologs

Rafael R. C. Cuadrat; Sérgio Manuel da Serra Cruz; Diogo A. Tschoeke; Edno Silva; Frederico Tosta; Henrique Jucá; Rodrigo Jardim; Maria Luiza Machado Campos; Marta Mattoso; Alberto M. R. Dávila

A key focus in 21(st) century integrative biology and drug discovery for neglected tropical and other diseases has been the use of BLAST-based computational methods for identification of orthologous groups in pathogenic organisms to discern orthologs, with a view to evaluate similarities and differences among species, and thus allow the transfer of annotation from known/curated proteins to new/non-annotated ones. We used here a profile-based sensitive methodology to identify distant homologs, coupled to the NCBIs COG (Unicellular orthologs) and KOG (Eukaryote orthologs), permitting us to perform comparative genomics analyses on five protozoan genomes. OrthoSearch was used in five protozoan proteomes showing that 3901 and 7473 orthologs can be identified by comparison with COG and KOG proteomes, respectively. The core protozoa proteome inferred was 418 Protozoa-COG orthologous groups and 704 Protozoa-KOG orthologous groups: (i) 31.58% (132/418) belongs to the category J (translation, ribosomal structure, and biogenesis), and 9.81% (41/418) to the category O (post-translational modification, protein turnover, chaperones) using COG; (ii) 21.45% (151/704) belongs to the categories J, and 13.92% (98/704) to the O using KOG. The phylogenomic analysis showed four well-supported clades for Eukarya, discriminating Multicellular [(i) human, fly, plant and worm] and Unicellular [(ii) yeast, (iii) fungi, and (iv) protozoa] species. These encouraging results attest to the usefulness of the profile-based methodology for comparative genomics to accelerate semi-automatic re-annotation, especially of the protozoan proteomes. This approach may also lend itself for applications in global health, for example, in the case of novel drug target discovery against pathogenic organisms previously considered difficult to research with traditional drug discovery tools.


Genome Announcements | 2014

Exploring the Genome of Cheese Starter Lactic Acid Bacterium Lactococcus lactis subsp. lactis CECT 4433.

Diogo A. Tschoeke; Ana Paula B. Moreira; Luciane A. Chimetto Tonon; Milene Mesquita; Gustavo B. Gregoracci; Bruno Gomez-Gil; Rogerio Valle; Cristiane C. Thompson; Fabiano L. Thompson

ABSTRACT Here, we present the draft genome sequences of Lactococcus lactis subsp. lactis CECT 4433, a cheese fermentation starter strain. The genome provides further insight into the genomic plasticity, biocomplexity (including gene strain specifics), and evolution of these genera.

Collaboration


Dive into the Diogo A. Tschoeke's collaboration.

Top Co-Authors

Avatar

Fabiano L. Thompson

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Cristiane C. Thompson

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Luciana Leomil

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Louisi de Oliveira

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Alberto M. R. Dávila

Empresa Brasileira de Pesquisa Agropecuária

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno Sergio de O. Silva

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thiago Moreno L. Souza

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Ana Carolina Soares

Federal University of Rio de Janeiro

View shared research outputs
Researchain Logo
Decentralizing Knowledge